|
China Medipharm Insights. Issue 7, Dec 1996· MEDICAL EQUIPMENT Sales of Medical Devices in East China were Fair in 1st Half of 1996 · MARKET ANALYSIS A 47.8% Decrease in Sales of Health Products in East China in the First Half of 1996 Aspirin: an Analysis of Production and Sales Trends · FEATURE ARTICLE Nationwide Reform of Healthcare System Getting into Gear · NEW REGULATION Chinese Government Wants a New Order over Drug Pricing Control · NDC GRANTING PROFILE 35 New Biological Products Obtained Clearance of MPH in 1st Half 1996 · PHARMACEUTICAL MARKET Guangzhou Trade Fair Reports a 35% Decline in Sales of Medicines & Health Products; Ten Pharmaceutical Chemicals Prospective in Export; Chinese Drugs Warmly Welcomed in India · PRODUCT NEWS Equipment: OUR-XGD Rotating Gamma Knife Obtained ISO 9000 Certificates; Chinese X-Knife Reached International Standards; Medicines: EPO; Chinese G-CSF; Clinical Reexaminations on PAF; Norcardia Rubra Cell Well Skeleton; Haimen's Adriamycin Granted FDA Approval; Fluconazole; 6-APA; Ciprofloxacin Chloride Tablet; Sea-Buckthorn Oil; Fosfomycin; Cefalexin Capsule; Soft Capsule of Nifedipine; Gliclazide; · INFORMATION SYSTEM First Satellite Consultation and Healthcare System; Remote Diagnostic Network Center; · COMPANY PROFILE Major Merger of Chemical and Pharmaceutical Groups; Shanghai Boehringer Ingelheim SINE Pharm. Lays a Foundation; First JV of B-D; Shanghai J&J; Novo-Nordisk's R&D Center; Kaken's Cooperative Project; Representative Office of Lotus; Genset; Suzhou Cynosure Medical Devices Co., Ltd.; North China Pharm. Became the First Licensee to Produce Genetic Engineering Vaccines; Shanxi Guardian Pharm.; Information Co.; The Largest Blood Purification Project; Amino-Acid Plant; Yuyao Pharmaceutical Factory Bankrupt; · NEWS IN BRIEF First Nuclear Medicine Biotech Center; Sino-German Center; HIV a Big Threat; Laser Micro-Operation System; Qingchunbao Embraced Hu Qing Yu Tang; Shanghai Squibb Celebrates Tenth Anniversary of Theragran; Beijing Administrative Regulations on Experimental Animals; One Million RMB for a Deputy Executive Manager; Capsule Production Line; · TECHNICAL INNOVATION Technical Innovation Project of Bio-product Base; Technical Innovation Project of Gentamycin; Vecuronium Bromide Technical Innovation Project; GMP Innovation Project of Tablet Workshop; Technical Innovation Project of Naproxen; GMP Innovation Project; · ADMINISTRATIVE PROTECTION Application of Avondale's Clotrasone Regarded as Voluntary Withdrawal; Approval Announcements Granting Administrative Protection; Recent Applications for Administrative Protection. |
|